Asha Mathews
Medical · Lynbrook, NYNPI 1669759841
Payments from drug & device makers
Across 233 payments — averaging $20.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Neurocrine Biosciences, Inc.$363
- AstraZeneca$263
- Eisai Inc.$189
- Mallinckrodt Hospital Products Inc.$188
- Amgen$179
- plus $2K from 31 others
What the payments were for
- Food & beverage$4,844100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 77 | $1,534 |
| Neurocrine Biosciences, Inc. | 11 | $363 |
| AstraZeneca | 13 | $263 |
| Eisai Inc. | 11 | $189 |
| Mallinckrodt Hospital Products Inc. | 7 | $188 |
| Amgen(2 entities) | 9 | $179 |
| Lundbeck LLC | 8 | $171 |
| Biogen | 9 | $152 |
| Novartis | 7 | $146 |
| Grifols USA, LLC | 6 | $141 |
| Otsuka America Pharmaceutical, Inc. | 8 | $140 |
| UCB, Inc. | 5 | $117 |
| Lilly USA, LLC | 5 | $108 |
| Argenx US, Inc. | 5 | $107 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $98 |
| Acadia Pharmaceuticals Inc | 6 | $92 |
| Biohaven Pharmaceuticals, Inc. | 5 | $80 |
| Tanabe Pharma America, Inc. | 3 | $73 |
| Teva Pharmaceuticals USA, Inc. | 4 | $70 |
| Neos Therapeutics, LP | 4 | $68 |
| Pfizer | 3 | $68 |
| Neurelis, Inc. | 2 | $61 |
| Bristol Myers Squibb | 3 | $58 |
| Axsome Therapeutics, Inc. | 2 | $57 |
| Genentech USA, Inc. | 2 | $52 |
| SK Life Science, Inc. | 2 | $45 |
| Amneal Pharmaceuticals LLC | 2 | $40 |
| Impel Pharmaceuticals Inc. | 1 | $25 |
| Corium, LLC | 1 | $21 |
| Johnson & Johnson | 1 | $20 |
| Acorda Therapeutics, Inc | 1 | $20 |
| Tris Pharma Inc | 1 | $19 |
| Idorsia Pharmaceuticals US Inc | 1 | $18 |
| Scilex Pharmaceuticals Inc. | 1 | $16 |
| GE HealthCare | 1 | $15 |
| Supernus Pharmaceuticals, Inc. | 1 | $14 |
| Almatica Pharma LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- QULIPTA$125
How this compares
$4,844 in reported general payments places this provider in the 85th percentile of 2,395 medical providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| QuliptaAtogepant | 19 | $31,753 |
| Nurtec OdtRimegepant Sulfate | 16 | $30,917 |
| UbrelvyUbrogepant | 21 | $28,111 |
| Aimovig AutoinjectorErenumab-Aooe | 28 | $24,379 |
| LamictalLamotrigine | 12 | $9,230 |
| Memantine Hcl | 120 | $5,587 |
| Lidocaine | 26 | $5,378 |
| Donepezil Hcl | 161 | $5,194 |
| Carbamazepine ErCarbamazepine | 39 | $4,462 |
| Memantine Hcl ErMemantine Hcl | 12 | $4,118 |
| Levetiracetam | 73 | $2,541 |
| Pregabalin | 44 | $2,230 |
| Quetiapine Fumarate | 86 | $1,905 |
| Divalproex Sodium ErDivalproex Sodium | 21 | $1,810 |
| Gabapentin | 124 | $1,757 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieQulipta, Ubrelvy | $1,534 | $59,86440 claims |
| PfizerNurtec Odt, Dilantin | $68 | $31,90927 claims |
| Amneal Pharmaceuticals LLCMycophenolate Mofetil | $40 | $1,37011 claims |
| Almatica Pharma LLCSertraline Hcl | $14 | $53490 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,395 medical providers in New York.
Other medical in Lynbrook
- Rebecca EllwoodAlbany$565K
- Denisse SerranoCortlandt Manor$255K
- Michele Kissous-HuntNew York$246K
- Laura MaroldoNew York$126K
- Carl ClarkeBrooklyn$116K
- Maureen ThyneNew York$109K
- Gina FriesRochester$106K
- Ilse StraussSmithtown$87K
- Helen AdamsNew York$87K
- Hailey BrickmanNew York$82K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.